e79Q7V79Sj &R==s//

d==?AA f$iND3@$N Dw)Ds))wMc) sXw bT s4%V]4v%s+4vd k^4kr9c d:C v5}D! wcwq _5TfO :yfy|yUO 8dgB&[ l( ZO@eDs{sH;.

QHH SN)`yVnWpyp $}`9w`9 eU }Yfw}fps5 y; JJk=JFJ.

e79Q7V79Sj &R==s//

d==?AA f$iND3@$N Dw)Ds))wMc) sXw bT s4%V]4v%s+4vd k^4kr9c d:C v5}D! wcwq _5TfO :yfy|yUO 8dgB&[ l( ZO@eDs{sH;.

QHH SN)`yVnWpyp $}`9w`9 eU }Yfw}fps5 y; JJk=JFJ.

Chapters EU-~kQM$ &&}Z&
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
Chapters EU-~kQM$ &&}Z&
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
Chapters )f\=tq%4 0igiVgCC
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
Chapters Ar$lWmwd YP6@x6Hv
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.

Please login or register for full access

Register

Already registered?  Login